(MENAFN- Ameliorate Solutions) Posted on October 16, 2021 by Market Insights Reports Dry Eye Disease (DED) Market 2021 Research and Clinical Analysis – Novartis International AG (Alcon Inc.), AbbVie Inc. (Allergan PLC), Otsuka Holdings Co., Ltd.
Global Dry Eye Disease (DED) Market Size and Forecast to 2021 – 2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This Market study provides comprehend Dry Eye Disease (DED) data that enhances the understanding, scope, and application of this report.
The study includes market share analysis and profiles of players such as Novartis International AG (Alcon Inc.), AbbVie Inc. (Allergan PLC), Otsuka Holdings Co., Ltd., Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., and Marinomed Biotech AG.
Click here to get a free sample copy of the latest research on Dry Eye Disease (DED) market ( USD $1800 ):
The global dry eye disease market is predicted to reach US$4.28 billion in 2024, witnessing growth at a CAGR of 5.23%, over the period 2020-2024.
Executive Summary:
The factors such as increasing geriatric population, growing burden of diabetes, rising healthcare expenditure, surging prevalence of arthritis and upswing in air pollution are expected to drive the market. A few notable trends include the emerging number of contact lens users, surge in laser eye surgeries, rising screen time and technological advancements and promising pipeline products. However, the market would be challenged by dearth of skilled professionals, increasing popularity of self-medication by patients and stringent regulations.
The global dry eye disease market has been segmented on the basis of type, product, treatment and distribution channel. On the basis of type, the global dry eye disease market can be bifurcated into aqueous & evaporative dry eye disease, evaporative dry eye disease and aqueous dry eye disease. According to products, the global market can be categorized into Restasis, Xiidra, Systane, Refresh and other products. Whereas, depending on the treatment, the global market can be split into anti-inflammatory drugs, artificial tears, punctual plug and other treatments. The global dry eye disease is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.
The fastest growing regional market is North America due to the rising burden of chronic diseases such as diabetes and rheumatoid arthritis in the region, increasing healthcare expenditure, presence of a well-developed healthcare sector, growing adoption of prescription dry eye disease drugs in the U.S. and increasing number of approvals for new drugs and devices from the FDA.
Key Target Audience:
– Pharmaceutical Companies
– Ophthalmic Drugs Manufacturing Companies
– Government and Private Laboratories
– Research and Development (R & D) Companies
– Government Bodies & Regulating Authorities
Browse the report description and TOC:
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Dry Eye Disease (DED) market.
The study objectives of this report are:
- To study and analyze the global Dry Eye Disease (DED) size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2023, and forecast to 2024.
- To understand the structure of Dry Eye Disease (DED) by identifying its various sub-segments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Dry Eye Disease (DED) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
- To analyze the Dry Eye Disease (DED) with respect to individual growth trends, future prospects, and their contribution to the total market.
- To project the value and volume of Dry Eye Disease (DED) submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Purchase full Report@:
Finally, the Dry Eye Disease (DED) Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Dry Eye Disease (DED) industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
Customization of the Report : This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.
MENAFN16102021004660010643ID1102980605
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.